You are a subscriber
If you are not already a subscriber,
Choose a subscription offer and create your account to read all content on MediapartCreate your account
An anti Covid-19 vaccine developed by US pharma firm Pfizer and Germany's BioNTech has been approved for use in France by the country's top health authority, the Haute Autorité de la santé (HAS), with vaccinations due to start on a voluntazry basis on Sunday, with a priority given for those most at risk.
Reading articles is for subscribers only. Subscribe now.